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Abstract
Meningioma arising in the inner third of the sphenoidal wing has beenwell recognized since the origin of neurosurgery, yet it still poses
a formidable challenge for the surgeon. Treatment strategies can be optimized through a tailored approach to surgical timing and use of
a non-surgical armamentarium. The aim of this study was to evaluate the long-term effect of different strategies on progression-free
survival and overall survival. We examined the clinical records of brain tumor patients to assess determinants for surgery (extent of
tumor removal, postoperative complications) and for progression-free survival and overall survival in relation to timing of surgery
eventually followed by stereotactic radiosurgery (SRS). The records of 60 patients were retrospectively reviewed, from preoperative
assessment to a median follow-up of 104 months. All were symptomatic with prevalently visual symptoms (42.2%), large tumors
(median diameter 3.44 cm), extension into the cavernous sinus (38.3%), and severe vascular involvement of one or more encased or
narrowed vessels (50%). Subtotal removal was achieved in 40% of cases, mainly determined by cavernous sinus and vascular
involvement; neurological complications occurred in 18.3% (persistent in 6.7% due to oculomotor and vascular injury). The overall
rate of symptom improvement was 32.3% at 3 months and 49.5% at 12 months. Radiological monitoring prevented clinical progres-
sion; tumor progression occurred in 11.7% of cases. There were significant differences in progression-free survival between patients
with (median 46months) and thosewithout (median 104months) recurrence (p = 0.002): 12.5% after total removal, 6.2% after subtotal
removal and adjuvant SRS, and 28.5% after subtotal removal and observation. The related Kaplan-Meier survival curve showed no
significant difference between the three strategies. Further, disease progression after recurrencewas noted in 28.6% of cases, but overall
survival was not influenced by either tumor recurrence or type of treatment. Treatment failure was recorded in four cases (6.7%): one
perioperative death and three later on. Surgery is themainstay for the treatment of symptomaticmeningioma and to restore neurological
function; however, resectability is limited by vascular and cavernous sinus involvement. Careful postoperative monitoring prevented
clinical progression and adjuvant or adjunctive SRS proved effective in tumor control. A low surgical complication rate and excellent
long-term outcomes were achieved with this strategy.
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Introduction
In the surgical management of meningiomas of the inner third
of the sphenoidal wing, the challenge for neurosurgeons is to
balance the risk of aggressive tumor surgery and potential
neurovascular complications with the risk of tumor progres-
sion [1–4]. Symptoms are often related to visual impairment;
their relief is the primary objective of the operation. However,
surgical anatomy and tumor behavior constitute pitfalls to
achieving safe removal. Infiltration of the skull base, tumor
calcification, vascular encasement, cavernous sinus
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involvement, contralateral, and posterior expansion are all for-
midable obstacles to managing these tumors [5–9].
Here, we report on long-term follow-up to retrospectively
recognize outcome determinants, compare three different
treatment strategies (aggressive vs. cautious removal, adjuvant
stereotactic radiosurgery (SRS), or observation), and evaluate
them at long term.
Material and methods
Between 2000 and 2012, a consecutive series of 60 patients
were operated on at our institution for inner third sphenoidal
wing meningioma with primary attachment to the anterior
clinoid process (ACP) and/or cavernous sinus (CS).
Meningiomas arising from the tuberculum sellae, middle and
lateral portion of the sphenoidal wing, and non-exophytic
mass of the cavernous sinus were excluded. Histology was
reclassified according to 2007 World Health Organization
(WHO) classification criteria [10]. Patient demographics,
clinico-radiological features, and intraoperative findings were
retrospectively reviewed and analyzed against the outcomes in
the acute and delayed phase.
In the acute phase, clinical status was assessed at 7 days
and again at 3 months by comparing symptoms and signs with
preoperative assessment. The two perioperative end points
were extent of surgical removal and complications. The extent
of removal was classified according to a two-tiered classifica-
tion system: total, i.e., without residual measurable mass, with
or without dural replacement or dural coagulation, and subto-
tal, i.e., with residual mass as determined by postoperative
magnetic resonance imaging (MRI). Complications were clas-
sified as local (tumor bed hemorrhage, wound infection, and
epilepsy), neurological (new or worsened symptoms and
signs), and systemic (respiratory and heart failure, sepsis,
thromboembolic events, etc.).
In the delayed phase, clinical status was assessed at
12 months and at the last control visit by comparing symp-
toms, signs, and Karnofsky Performance Status (KPS) with
preoperative assessment. Additional end points were as
follows: occurrence of regrowth or recurrence, progression-
free survival, and overall survival. All patients were moni-
tored with MRI. Progression-free survival was defined as the
interval between treatment and tumor regrowth or recurrence.
Regrowth was defined as tumor progression as documented
by follow-up MRI after subtotal removal and recurrence after
total removal. Overall survival was the time interval between
treatment and the last event: tumor progression or death versus
tumor stabilization.
Ethical committee approval was not sought because data
collection did not influence the patient management in any
way.
Clinico-radiological features
Presenting symptoms and signs and length of clinical his-
tory were recorded. Multiplanar contrast-enhanced MRI
and contrasted computerized tomography (CT) scans,
with and without bone window, were performed before
surgery. Angiography, angio-MRI, or 3D angio-CT scans
were obtained to better evaluate the relation between the
lesion and the arteries of the anterior circle of Willis, i.e.,
internal carotid artery (ICA), middle cerebral artery
(MCA), and anterior cerebral artery (ACA, A1-A2).
Preoperative embolization of the tumor feeding arteries
was not performed in this series. The relation between
meningioma and vessels was classified as no contact, con-
tact, displacement, encasement, and narrowing. Vessel
names and number and type of involvement were record-
ed. As the lesions presented a spherical shape, the vol-
umes were measured according to modified MacDonald
ellipsoid criteria [11]. The mean diameter was calculated
as the sum of the three largest diameters divided by three,
and the direction of tumor extension was described.
Edema was classified as absent, perilesional (< 2 cm), or
massive.
Treatment strategies
Treatment included surgical resection as first-line treatment
and stereotactic radiosurgery (SRS) with Leksell instrumenta-
tion. The standard surgical approach consisted of pterional
craniotomy and transsylvian approach to the tumor in all
cases, with additional steps on a case-by-case basis (optic
canal unroofing, clinoidectomy, and apical orbitectomy).
Particular attention was paid to decompressing the optic nerve
in patients with visual impairment. Type of vascular involve-
ment, arachnoidal cleavage plane with regard to the brain and
the vessels, tumor consistency, and bleeding were recorded
and evaluated.
SRS procedures were performed with a model C 201-
source Co60 Leksell Gamma Unit and, since June 2008,
with Gamma Knife (GK) Perfexion (both from Elekta
Instruments). Three-dimensional treatment planning was
developed using Leksell Gamma Plan (versions 4.12,
5.34, and 8.3; Elekta Instruments). Neuroradiological lo-
calization was routinely performed using stereotactic
MRI with specific algorithms and sequences: 1-mm-
isovoxel volumetric, T1 fat saturated, and steady-state
gadolinium-enhanced images. Mean and range dose
planning parameters were as follows: gross target vol-
ume (GTV 9.4 cc, 1.22–29.6), prescription dose (PD
12.01 Gy, 10–15), prescription isodose (PI 47.6%, 30–
60), maximum dose (MD 23.8 Gy, 20–28), and shot
number (11.5, 1–31). SRS was characterized by PD
and MD intensity delivered in compliance with the optic
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nerve, the chiasm, and the pituitary peduncle. SRS was
offered as adjuvant treatment in patients with postoper-
ative remnants or as adjunctive treatment at tumor
progression.
Statistical analysis
Significance of differences between patients for the three end
points, extent of surgical removal (total/subtotal),
Table 1 Time course of symptoms and signs
Preoperative Postoperative course compared with preop
7 days 3 months 12 months† Total
n, % New ↓ ↑ = ↑ = ↑ = ↑, % =, %
Headache 19, 21.1 – – 6 13 1 12 2 10 9, 9.1 10, 10.1
Monocular visual impairment (> 3/10) 13, 14.4 – – 4 9 2 7 – 7 6, 6.1 7, 7.1
Monocular severe visual impairment (< 3/10) 9, 10 – – 1 8 1 7 3 4 5, 5.1 4, 4
Binocular mild visual impairment (> 3/10 in both eyes) 1, 1.1 – – 1 – – – – – 1 1 –, 0
Binocular severe visual impairment (at least < 3/10 in one eye) 4, 4.4 – – 2 2 – 2 – 2 2, 2 2, 2
Visual field deficit 11, 12.2 1 – – 11 – 12 3 9 3, 3 9, 9.1
Diplopia 3, 3.3 3 – – 3 – 6 2 4 2, 2 4, 4
Epilepsy 15, 16.7 1 1 1 13 4 11 3 8 8, 8.1 8, 8.1
Cognitive problems 5, 5.6 1 1 3 1 1 2 2 – 6, 6.1 –, 0
Motor impairment 5, 5.6 2 – 1 4 – 6 1 5 2, 2 5, 5.1
Other* 5, 5.6 1 – 3 2 1 3 1 1 5, 5.1 1, 1
Total 90, 100 49/99♦, 49.5 50/99, 50.5
< 70 1 3
KPS = 70 10 4
> 70 49 48
New number of patients with new symptoms registered after surgery, ↓ number of patients that worsened after surgery, ↑ number of patients that
improved or returned to normal status, = number of patients that remained stable
*Other: facial hypesthesia, retrobulbar pain
† Four patients were lost at 12-month follow-up; one other patient died after first operations
♦At 3- and 12-month evaluation, patients were compared with preoperative symptoms/sign and postoperative new symptoms and signs (total n = 99)
Table 2 Radiological findings
Mean Range
Size
Tumor diameter ([x + y + z]/3; cm) 3.44 ± 1.09 1–5.33










Petrous apex - posterior fossa 6 10
Across the midline 4 6.7
2 or more locations 29 48.3
Edema
Absent 13 21.7
Perilesional (< 2 cm) 23 38.3
Massive (> 2 cm) 24 40
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complications (present/absent), and tumor regrowth or recur-
rence (present/absent) were evaluated using Fisher’s exact test
for categorical variables and by the Wilcoxon–Mann–
Whitney non-parametric test for continuous variables.
Variables were as follows: age, sex, KPS, symptoms/signs,
tumor volume, tumor extension, edema, main vessel involve-
ment (ICA, MCA, ACA), degree of vascular involvement,
arachnoidal plane around both vessels and brain, tumor con-
sistency, and tumor bleeding. Additional variables related to
treatment were extent of surgical removal and eventual adju-
vant SRS for determinants of regrowth/recurrence.
Progression-free survival curves were generated using the
Kaplan–Meier method, and statistical significance was deter-
mined using the log-rank test according to treatment strate-
gies: total removal, subtotal removal, and subtotal removal
with adjuvant SRS. All p values were two-sided, and a p value
of < 0.05 was considered statistically significant. Statistical
analyses were performed using Stata 14.0 (StataCorp,
College Station, TX, USA).
Results
A total of 39 women and 19 men (ratio 2.05:1; mean age 57 ±
15 years, range 22–87) were operated on for the first time for
meningioma arising from the inner portion of the sphenoid wing.
Clinico-radiological features
Preoperatively, visual acuity and visual field deficits
accounted for 42.2% (n = 38) of signs and symptoms in
31 patients (51.7%). Headache and epilepsy were present
in 19 (31.7%) and 15 (25%), respectively. Overall, the
number of patients with KPS > 70 was 49 (81.7%)
(Table 1).
Radiological findings are reported in Tables 2, 3, and 4
(Figs. 1, 2, and 3). The primary location of meningioma was
the ACP in 55 (91.7%) cases and the CS in the remaining 5
(8.3%). The most frequently occupied secondary sites were the
CS in 18 (30%), the parasellar area in 14 (23.3%), and the sellae
in 8 (13.3%). Two or more sites were found in 29 (48.3%)
cases. The preoperative mean tumor volume was 27.1 cm3
(range 0.52–77.75) and the mean diameter was 3.44 ±
1.09 cm (range 1–5.33). Tumor volume and extension
accounted for a large tumor series. Edema was present in
78.3% of cases (Table 2). Integration of radiographic findings
and operating notes made it easier to understand the involve-
ment of the adjacent vascular structures: the ICAwas the most
severely affected vessel (encasement) (n = 26, 43.3%); the
MCA was the most often displaced vessel (n = 30, 50%), and
the ACA, A1-A2 had no contact with the tumor in the majority
of cases (n = 40, 66.7%) (Table 3). In addition, a new parameter
was added to the analysis: degree of vascular involvement.
Three groups were recognized with a higher degree of vascular
involvement (encasement and narrowing) based on the number
of vessels entrapped in the tumor (n = 30, 50%): one group (n =
14, 46.7%) with only ICA involvement in 92.9% of cases, a
second group (n = 10, 33.3%) with ICA-MCA involvement in
90%, and a third group (n = 6 20%) with ICA-MCA-ACA (A1-
A2) involvement in all 6 cases (Table 4).
Surgical treatment
Surgery was performed at 13 months after the onset of
symptoms (ranging from a few weeks to 94 months).
Total removal was obtained in 36 (60%) cases. In the
remaining 24 (40%), the residual mass measured less than
2 cm in 16 cases (26.7%) and less than 3 cm in 8 (13.3%).
The factors limiting achievement of total removal were
infi l trat ion of the CS in 75% (n = 18) of cases,
encasement/invasion of adjacent neurovascular structures
in 41.7% (n = 10), tumor consistency in 12.5% (n = 3),
and bleeding in 8.3% (n = 2) (Figs. 2 and 3). Atypical
meningiomas were observed in 3 patients, with total re-
moval achieved in two of them.
Significant predictors of incomplete removal in order of
importance were as follows: degree of vascular involvement
(p < 0.001), ICA involvement (p < 0.001), CS invasion (p <
0.001), tumor volume (p < 0.01), cleavage plane around ves-
sels (p < 0.01), and tumor consistency (p < 0.01).
Table 3 Vascular involvement
No. %
ICA

















ICA denotes internal cerebral artery, MCA middle cerebral artery, ACA
anterior cerebral artery
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Perioperative outcome
Recovery of presenting deficits was observed within the first
7 days after surgery in 21 (35%) patients, then much slower in
the following months. An example is the effect of decompres-
sion on optic function, since visual acuity was improved in
29.6% of patients (n = 8) (Table 1).
Local complications occurred in 4 patients (6.7%), systemic
in 5 (8.3%), and neurologic in 11 (18.3%), due to new distur-
bances that later improved at 3 months in 7 cases but persisted in
4 (6.7%) (hemiparesis due to vascular injury and diplopia in 2
cases each) (Table 5). The only significant predictor for compli-
cations of any type was KPS ≤ 70 (p< 0.01). One patient died
(1.7% of perioperative mortality) a few days after the operation
because of malignant endocranial hypertension due to severe
cerebellar Bzebra sign^ hemorrhage and hydrocephalus.
Follow-up and final outcome
Four patients were lost to follow-up at 5–12 months after
surgery, and 55 patients could be traced in a timeframe
between 12 and 290 months. Improvement was noted for
visual disturbances (acuity and field disturbances) in 16
patients (51.6%), headache in 9 (47.4%), and epilepsy in
8 (50%) (patients without epileptic fits without antiepilep-
tic therapy). Forty-eight (87.3%) patients were indepen-
dent (Table 1).
Sixteen out of 23 patients with subtotal removal underwent
subsequent adjuvant SRS between 2 and 12 months after sur-
gery. Themean PDwas 12.01 Gy (range 10 to 15) and theMD
was 23.8 Gy (range 20 to 28); 7 patients underwent observa-
tion, as done for all the patients in the total removal group (n =
32). Of the 39 patients who were followed by observation, 6
experienced recurrence: 4 (12.5%) in the total removal group
at a mean 58 months, 2 of which progressed to atypical me-
ningioma at recurrence 48 and 160 months after initial sur-
gery, and 2 in the subtotal removal group (28.6%) at a mean
22 months. Another recurrence occurred at 46 months in a
patient who had received subtotal removal with adjuvant
SRS (6.2%).
Five patients underwent SRS for disease recurrence, one of
which had tumor progression at the most recent follow-up
visit, and two underwent more than one operation followed
by SRS. The median progression-free survival was 46 months
(range 14–160) and differed significantly from the 104months
(range 12–211) noted for the patients without relapse (p =
0.02).
Preoperative volume was found to be the only factor associ-
ated with tumor regrowth/recurrence (p = 0.01). Progression-
free survival was estimated with the Kaplan–Meier method
after recording the type of treatment as a three-level variable
(total removal vs. subtotal removal vs. subtotal removal with
adjuvant SRS). No significant differences were observed be-
tween the three treatment strategies (Fig. 4).
In addition, tumor recurrence was noted in two of the
three patients with atypical meningioma: total removal
was performed in one and adjuvant SRS in another case
at 66 and 22 months, respectively, for a total of nine
relapses (16.4%). Three out of five patients with atypical
meningioma at recurrence died after reoperation and/or
SRS a mean 83 months after initial surgery. The median
overall survival was 104 months (range 0–290),
104 months (range 12–211) without relapse, and
114 months (range 81–290) with relapse.
Table 4 Degree of vascular
involvement Group I Group II Group III








No. of cases 13 1 – 1 – 9 6
Vessel encasement and/or narrowing was present in 30 patients (50%)
ICA denotes internal cerebral artery, MCA middle cerebral artery, ACA anterior cerebral artery
Fig. 1 MR enhanced T1-weighted images on coronal view showing
clinoidal hyperostosis, site of attachment, distortion of the chiasm, and
vicinity of the carotid artery. Note that the cavernous sinus is not occupied
by the tumor
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Discussion
Since 1990, medial sphenoid wing meningiomas have been ex-
tensively studied, thanks to a work by Al-Mefty [5] who identi-
fied clinoidal meningiomas and its subgroups including cavern-
ous sinus involvement. Medial sphenoid wing meningiomas can
occupy both areas (clinoidal and cavernous) and extend beyond
them [12]. The distinctive features are primary attachment (either
of the two, keeping in mind that clinoidal meningiomas may
extend to the cavernous sinus rather than the contrary) and type
of cavernous sinus involvement, since the lateral wall may be
peeled away from the tumor, while medial occupation with ca-
rotid encasement is a surgical limitation [13–16]. Our observa-
tion of primary invasion in 8.3% of cases and secondary invasion
in 30% is shared by Russell et al. (31.4%) [8] but not by
Nakamura et al. (63.9%) [12]. The growing experience with this
type of tumor makes Al Mefty’s inference about the arachnoidal
plane around the ICA and its main trunks unlikely, invaliding the
same classification. As a consequence, both tumors are surgical
targets for debulking and functional improvement, with the
arachnoidal plane being difficult to predict yet often present [6,
8, 17]. Further detailed description of tumor site is feasible only
in small or middle-sized tumor. Bassioumi et al. [17] and Pamir
et al. [18] described a tumor subgroup with better prognosis, i.e.,
tumors extending only into the anterior cranial fossa, above the
clinoid, because of improbable vascular adhesions. Nakamura
described a medial and a lateral group of tumors of the inner
sphenoidal wing, with the medial involving the cavernous sinus
and the lateral lying outside with less vascular involvement [12].
Clinico-radiological features
Clinical and radiological features are often closely linked.
Tumor size typically affects the visual apparatus, by far the
most frequently involved nervous structure. In this series of
large tumors (mean diameter 3.44 cm and 48.3% of cases with
Fig. 2 MR enhanced T1-weighted images on coronal view and angiog-
raphy showing the ICA and its branches (A1 and MCA) encased in the
tumor (a, b). Postoperative coronal view showing complete removal of
the intradural part with some remnants in the cavernous sinus (c). This
patient did not undergo adjuvant SRS and the tumor is stable so far
(58 months after surgery)
Fig. 3 Preoperative coronal view on MR enhanced T1-weighted images showing primary exophytic cavernous sinus meningioma (a). Postoperative
scans showing cytoreduction (b). This patient underwent adjuvant SRS
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extension into neighboring areas), visual symptoms were
present in 51.7% of cases, followed by headache and epilepsy
[5, 19–21].
The relation of the carotid artery with the tumor was clas-
sified by Hirsh et al. [22] and Behari et al. [23]. However,
depending on site of tumor attachment, size, and extension,
it is not the only vessel involved. We found a different pattern
of severe vascular involvement whose extent was seen to in-
crease surgical risk and therefore merits special attention.
Calcifications were noted in 23.3% of cases, often limited to
the clinoid rather than to the majority of the tumor mass [20,
22]. Pneumatized clinoid should be investigated for the risk of
rhinorrhea (Fig. 1) [24]. Massive edema may have several
different pathological meanings: effect of angiogenetic fac-
tors, expression of malignancy, compression of the sylvian
veins, which is merely a mechanical obstacle of low prognos-
tic importance [10, 24].
Extent of surgical removal
Surgical features are not consistent across clinical series; total
removal varies from 30 to 77% probably due to the intrinsic
heterogeneity of this group of meningiomas in which the main
determinants of surgical outcome are clear [9, 12, 17, 25, 26].
Tumor extension into the cavernous sinus or controlaterally,
encasement of the ICA and its main trunks, tumor size, arach-
noid cleavage, and tumor consistency remain, in order of im-
portance, the main predictors for subtotal removal in most
series published to date including ours. This is borne out by
the relative number of classification systems [4, 8, 18, 20, 23,
27]. We found that the extent of vessel encasement and
narrowing is a major limitation, more so than the involvement
of a single portion (carotid vs. middle cerebral artery vs. an-
terior cerebral artery). In addition, the anfractuosity of the
dural folds in this small area makes it highly probable that
nests of cells will be left in site, providing an opportunity for
the tumor to recur even after total removal (12.5% in our
series, similar to others) [5, 12, 17, 26, 28].
Functional outcome
Refining technical steps like early unroofing of the optic ca-
nal, clinoidectomy, and apical orbitectomy have led to safer
management of the optic nerve and precocious identification
of the carotid artery, which are key elements for enhancing
visual improvement and safety [6, 7, 9, 18, 29–31]. In larger
tumors, if the tumor burden cannot be managed, the site of
attachment at the distal course of the middle cerebral artery
can be followed backwards to the carotid bifurcation, using
the vessels as a guide to split the tumor before further
debulking [17, 32]. We fully share this surgical strategy, hav-
ing often identified an arachnoidal plane around the vessels
even in those that were encased and narrowed [8, 19].
Surgical technique has dramatically improved functional
outcome and lowered the rate of vascular complications from
45 to 4%. This has drawn attention to a critical factor limiting
surgical removal, i.e., the firm adhesion between tumor and
vascular adventitia [12, 18, 33]. In the present study, taking
together local, neurological (including vascular), and systemic
complications, the overall neurological complication rate was
18%, of which only 6% persisted at 3 months (50% ocular
Table 5 Perioperative





Neurological + local 2 3.3
Neurological + systemic 2 3.3
Total local 4 6.7
Total systemic 5 8.3
Total neurological 11 18.3
Fig. 4 Kaplan–Meier curve.
Progression-free survival was es-
timated based on the type of
treatment as a three-level variable
(total removal vs. subtotal re-
moval vs. subtotal removal with
adjuvant SRS). There were no
significant differences between
the three treatment modalities
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cranial nerves and 50% vascular complications, respectively).
The type of long-term consequences was similar to previous
studies [12, 17, 23, 34]. Oculomotor impairment was also
reported as the most frequent persistent deficit (range 8 to
41%) possibly due to aggressive clinoid drilling [5, 24, 25,
35].
Long-term visual improvement ranged between 40 and
77% [5, 9, 12, 17, 36], while impairment remained stable
between 14 and 22% [17, 25]. Predictors of visual outcome
have been assessed by Margalit et al. [35] who reported on
preoperative degree of visual impairment, tumor size, and op-
tic nerve encasement, while Chaichana et al. [37] reported on
preoperative visual acuity, subtotal removal, and recurrent tu-
mor. In the past, less attention was given to other symptoms/
signs. All patients in the present series were symptomatic be-
fore surgery and improved at 12 months after surgery with a
KPS > 70 in 87.3% of cases.
Recurrence and survival
In medial sphenoidal wing meningioma, especially in CS me-
ningioma, SRS has been demonstrated effective on residual
tumor to prevent tumor progression [14, 37–41]. The present
study may provide some answers for clinical management
based on validated treatments with different strategies (total
vs. subtotal removal and adjuvant vs. adjunctive SRS), the
longest follow-up published in the literature (median
104 months), and the median progression-free survival con-
sistently observed within 60 months [17].
The type of surgical removal did not influence malignant
transformation into atypical meningiomas, even though the
number is limited, which per se is a major determinant for
recurrence and survival. Early SRS was noted to prevent re-
growth as compared with observation (regrowth rate 6.2% vs.
28.6%), whereas delayed treatment, at recurrence/regrowth,
seemed to be less effective (regrowth rate 20%, albeit with a
limited number). These clinically meaningful differences were
not statistically significant for progression-free survival or
survival.
Two main reasons to delay SRS are as follows: the risk of
scarring caused by SRS, which is an adverse factor for both
safety and extent of surgical removal in case of need for reop-
eration, and the indolent biological behavior of CS meningi-
omas [5, 8, 13, 16, 17]. In any case, convergent results indicate
that the main objectives of surgery are to reduce the mass to
improve the patient’s quality of life, reduce the risk of re-
growth, and facilitate further treatment [4, 28, 38, 39, 41, 42].
Conclusions
Surgery remains the gold standard for the treatment of symp-
tomatic meningioma of the inner sphenoidal wing. Based on
clinical and radiological findings, the surgical risk can be esti-
mated with fairly good precision—but not completely because
arachnoidal cleavage around vessels is an (often favorable) in-
traoperative determinant. The major determinants for extent of
surgical removal are tumor extension in the CS and degree of
vascular involvement. The mortality rate in this series was
1.7%. Because they can be persistent, vascular and oculomotor
complications increase the risk of diminished quality of life
(6.7%). Although the Kaplan–Meier curve did not show a sig-
nificant difference in progression-free survival between the
three strategies (observation after total removal, observation
after subtotal removal, and adjuvant SRS after subtotal remov-
al), we noted that early SRS was associated with lower re-
growth rate (6.2% vs. 28.6%). Our cautious approach to dealing
with tumor adherent to vessels or invading the CS has yielded
very good results with low mortality, low rate of persistent
complications, and excellent long-term tumor control.
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